Site map

• TreatHIV homepage
• HIV medications
• Nucleoside Reverse Transcriptase Inhibitors or "Nucs"
• Non-Nucleoside Reverse Transcriptase Inhibitors or "Non-nucs"
• Protease Inhibitors or PIs
• Fusion Inhibitors or FIs
• Stay on track
• The importance of adherence
• What is resistance?
• Monitoring treatment
• Side effects
• Switching treatment
• Bridges to Access
• Talking with your healthcare provider
• Newly diagnosed
• In treatment
• Caregivers
• GSK's commitment
• Hope After HIV
• Positive Action
• HIV resources
• Patient resources
• Finding a clinical trial
• Glossary
• Helpful links
• Important Safety Information/Indications
• LEXIVA^® (fosamprenavir calcium)
• EPZICOM^® (abacavir sulfate and lamivudine)
• COMBIVIR^® (lamivudine/zidovudine)
• TRIZIVIR^® (abacavir sulfate, lamivudine, and zidovudine)
• ZIAGEN^® (abacavir sulfate)
• EPIVIR^® (lamivudine)
• RETROVIR^® (zidovudine)